Chief Executive Officer and Co-Founder
Dr. Siciliano co-founded Invisible Sentinel in 2006 and was the lead inventor of the Company’s Veriflow technology. In his role as CEO, he sets corporate strategy, including sales and marketing initiatives and the identification of strategic partnerships. He also leads the R&D team, drawing on his more than 15 years of experience in microbiology, immunology, and assay development. He earned a B.S. in Chemistry from Villanova University and a Ph.D. in Immunology & Microbial Pathogenesis from Thomas Jefferson University. Formerly, Nick was a biomedical researcher in bacterial and viral pathogenesis, immunology, microbiology, and oncology, as well as a developer of antibody-based assays and consultant on projects in bacteriology, immunology, and antibody design. He has received several awards including Honoree on the annual “40 under 40” list compiled by the Philadelphia Business Journal to recognize outstanding entrepreneurs and business leaders. He was also a recipient of the 2015 Marcum/Smart CEO Innovator of the Year.
Chief Business Officer and Co-Founder
Mr. Pascal co-founded Invisible Sentinel in 2006. In his role as Chief Business Officer, he focuses on marketing and business development. He also works closely with the Sales function of the Company, helping to define sales strategies, identifying potential clients, supporting system implementation at key corporate accounts, and opening new international markets for the Company. Formerly he was a product developer at B. Braun Medical and the National Institute for Medical Research (London). Ben is an inventor on a corresponding patent to an antibacterial device and team member in the design of a functional cellular vaccine against malaria. He received a BS degree from The George Washington University in Biology and Political Science and an MBA from Lehigh University.
Chief Financial Officer
Mr. Crowley joined Invisible Sentinel in early 2019 as the CFO following the acquisition from bioMerieux leading the finance, accounting and corporate integration functions. William brings 20 years of industry/diagnostics experience with roles in R&D and International Internal Audit & Business Control for Saint-Gobain and held regional and global leadership roles in Purchasing and bioMerieux. He earned a B.S. in Natural Sciences from Worcester State University and an MBA from Clark University both located in Worcester, MA.
Vice President, Operations
Mr. Courtney directs manufacturing for the complete line of Veriflow test kits at Invisible Sentinel’s production facility at the University City Science Center in Philadelphia. He is responsible for Good Manufacturing Practices (GMP) and efficient delivery required to ensure that every Invisible Sentinel customer will benefit from the inherent advantages of Veriflow® technology. Prior to joining Invisible Sentinel, Patrick was the director of process-improvement and quality-assurance programs in various companies, including Medco Health Solutions, Fresenius Medical Care, and Centocor, Inc., and he is a Six Sigma Master Black Belt.
Director, Antibody Development
Ashley Brown is a Senior Scientist in R&D at Invisible Sentinel. Ms. Brown earned her B.S. in Biology from Drexel University and started at Invisible Sentinel as a part of Drexel's Cooperative Education program in 2009. She has been with the Company from its concept phase to where it is today. She has since been responsible for the development of many assays in the Veriflow product line. She continues to develop custom solutions for clients and leads junior scientists through product optimization initiatives.